Atlas Trials

Muscle Invasive Bladder Carcinoma

50 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Muscle Invasive Bladder Carcinoma

RecordFirmDate
Pembrolizumab in Muscle-invasive Bladder Cancer (NCT05406713)Matthew Galsky2022-07-13
A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer (NCT05297552)RemeGen Co., Ltd.2022-05-26
Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach (NCT05295992)Varian, a Siemens Healthineers Company2022-03-15
Clinical Performance Evaluation of the C2i-Test (NCT05221827)C2i Genomics2022-02-24
An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) (NCT04876313)IRCCS San Raffaele2022-01-27
Clinical Utility of VI-RADS in Diagnosis of MIBC (NCT05097404)Samsung Medical Center2021-09-09
Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder. (NCT04966130)Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2021-09-01
AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study (NCT05028660)Elypta2021-07-21
Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer (NCT04909775)Ruijin Hospital2021-07-01
Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer (NCT04724928)University Hospital, Ghent2021-04-29
Robotic Radical Cystectomy Outcomes (NCT04900558)University of Florence2021-04-29
a Genome-based Platform to Predict Patients That Can Achieve Bladder Preservation in Muscle Invasive Bladder Cancer Patients (NCT04686149)Yonsei University2021-01-01
Addressing Barriers to Palliative Care Use in Bladder Cancer (NCT04598724)H. Lee Moffitt Cancer Center and Research Institute2020-12-22
A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer (NCT04506554)Fox Chase Cancer Center2020-12-01
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer (NCT04383743)University of Washington2020-11-24
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC (NCT04610671)H. Lee Moffitt Cancer Center and Research Institute2020-10-26
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer (NCT03775265)National Cancer Institute (NCI)2019-06-03
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy (NCT02145390)University of Miami2016-01-05
Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy (NCT06170177)IRCCS San Raffaele2013-02-04

Track Muscle Invasive Bladder Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.